Welcome!

We hope that this page gives you a sense of the kind of work that we are doing in our lab here, the PTSD Treatment and Research Program – and the opportunities for students that are available. Our work is focused on intervention studies, primarily in the area of PTSD, but also in mood disorders. We are a busy, productive group. We routinely work on various grants and chapters which relate to our mission statement. We also work with randomized controlled trial (RCT) datasets from studies our lab has completed with our collaborators across the country. Below are descriptions of our current research projects.

Positive Processes and Transition to Health

Our primary active study in the lab is Positive Processes and Transition to Health (PATH), a NIMH-funded clinical trial. This is a multi-site trial in collaboration with Dr. Lori Zoellner at University of Washington and Dr. Adele Hayes at the University of Delaware. This project will be active until July 2027 and is an innovative treatment that targets maladaptive event processing (unproductive processing, avoidance, and anhedonia).

Individuals participating in the study will receive six sessions of individual therapy to treat symptoms of PTSD/Depression following a destabilizing or stressful event.
If you are interested in participating in PATH, please visit our study website:
https://pathway2help.com/

PATH is an individual treatment program for adults suffering from depression and trauma-related symptoms and also promotes parallel adaptive event processing (constructive processing, approach, and reward seeking) for destabilizing life events (e.g., financial stress, illness, death of loved ones, stressful events due to the COVID-19 pandemic, termination of a significant relationship). PATH broadly addresses stressor-related psychopathology and therefore can treat PTSD alone, depression alone, the combination, and subthreshold distress, grief, and impairment.